Pharmaceutical stocks, including Johnson & Johnson, AbbVie, Merck, AstraZeneca, Amgen, Sanofi, and Gilead Sciences, are predicted to experience negative selling pressure if the new tariffs are applied to them.
"So instantly, you most likely will see some negative selling pressure if these tariffs are applicable to them."
